Your browser doesn't support javascript.
loading
Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.
Siebert, Nikolai; Zumpe, Maxi; Schwencke, Christian Heinrich; Biskupski, Simon; Troschke-Meurer, Sascha; Leopold, Justus; Zikoridse, Alexander; Lode, Holger N.
Affiliation
  • Siebert N; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Zumpe M; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Schwencke CH; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Biskupski S; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Troschke-Meurer S; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Leopold J; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Zikoridse A; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
  • Lode HN; Department of Pediatric Oncology and Hematology, University Medicine Greifswald, 17475 Greifswald, Germany.
Cancers (Basel) ; 15(13)2023 Jun 23.
Article in En | MEDLINE | ID: mdl-37444427

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Germany Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2023 Document type: Article Affiliation country: Germany Country of publication: Switzerland